Skip to content

Clinical trials

Recruiting Glomerulosclerosis, Focal Segmental trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Status: Recruiting Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20212
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bio-Thera Solutions1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Everest Medicines (China) Co.,Ltd.1
George (Beijing) Clinical Research Co. Ltd.1
Hansoh BioMedical R&D Company1
Sanofi1
Zunsong Wang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental8
Glomerulonephritis, IGA4
Nephrosis, Lipoid4
Diabetic Nephropathies2
Glomerulonephritis, Membranous2
Kidney Diseases2
Glomerulonephritis1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.